By Aaron Jodka | June 2020

The second quarter of 2020 is one of the most important, numbers-wise, in recent memory. The COVID-19 pandemic and

By Aaron Jodka | June 2020

During the Great Recession that officially began at the end of 2007, housing was front and center. What happened —after

By Dion Sorrentino | June 2020

The COVID-19 pandemic has had a large and immediate negative impact on business and real estate, yet industrial is

By Aaron Jodka | June 2020

Last Monday was the first day that Mayor Walsh allowed nonessential office workers to return to work in Boston.

By Aaron Jodka | June 2020

Greater Boston’s life science market has been thriving and will continue to. Growth has occurred all over the region,

By Frank  Petz | June 2020

Thought it might be helpful to consolidate and share some insights on the capital markets more comprehensively as we

By Aaron Jodka | June 2020

As this is our 11th Disruption 2020 series post, we wanted to mix it up a bit and focus on some of the key numbers we

By Aaron Jodka | May 2020

Looking at first quarter numbers, the Boston investment sales market was rocking and rolling. Sales across the major

By Aaron Jodka | May 2020

With restrictions on the U.S. workforce easing, including Boston’s, the office market is in flux. Tenants who need to

By Aaron Jodka | May 2020

It’s no secret that Greater Boston, and Cambridge specifically, is the global leader in life science R&D. We are on the